![EISAI TO LAUNCH IN-HOUSE DEVELOPED NEW ANTI-INSOMNIA DRUG DAYVIGO® (LEMBOREXANT) WITH INDICATION FOR INSOMNIA IN JAPAN | News Release:2020 | Eisai Co., Ltd. EISAI TO LAUNCH IN-HOUSE DEVELOPED NEW ANTI-INSOMNIA DRUG DAYVIGO® (LEMBOREXANT) WITH INDICATION FOR INSOMNIA IN JAPAN | News Release:2020 | Eisai Co., Ltd.](https://www.eisai.com/news/2020/images/202036-01.jpg)
EISAI TO LAUNCH IN-HOUSE DEVELOPED NEW ANTI-INSOMNIA DRUG DAYVIGO® (LEMBOREXANT) WITH INDICATION FOR INSOMNIA IN JAPAN | News Release:2020 | Eisai Co., Ltd.
![A 2023 Update on Managing Insomnia in Primary Care: Insights From an Expert Consensus Group | Psychiatrist.com A 2023 Update on Managing Insomnia in Primary Care: Insights From an Expert Consensus Group | Psychiatrist.com](https://www.psychiatrist.com/wp-content/uploads/2023/01/22nr03385T2-scaled.gif)
A 2023 Update on Managing Insomnia in Primary Care: Insights From an Expert Consensus Group | Psychiatrist.com
![The quest for a good night's sleep: An update on pharmacologic therapy for insomnia | CHEST Physician The quest for a good night's sleep: An update on pharmacologic therapy for insomnia | CHEST Physician](https://cdn.mdedge.com/files/s3fs-public/157532c_graphic_web.png)
The quest for a good night's sleep: An update on pharmacologic therapy for insomnia | CHEST Physician
![The quest for a good night's sleep: An update on pharmacologic therapy for insomnia | CHEST Physician The quest for a good night's sleep: An update on pharmacologic therapy for insomnia | CHEST Physician](https://cdn.mdedge.com/files/s3fs-public/157532b_graphic_web.png)